Giant condyloma acuminatum

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Giant condyloma acuminatum
File:Condylomata gigantea.png
Synonyms	Buschke–Löwenstein tumor
Pronounce	N/A
Specialty	N/A
Symptoms	Large, cauliflower-like genital warts
Complications	Malignant transformation, local tissue destruction
Onset	Adulthood
Duration	Chronic
Types	N/A
Causes	Human papillomavirus (HPV) infection, primarily types 6 and 11
Risks	Immunosuppression, poor hygiene, chronic irritation
Diagnosis	Clinical examination, biopsy
Differential diagnosis	Squamous cell carcinoma, verrucous carcinoma
Prevention	HPV vaccination, safe sex practices
Treatment	Surgical excision, laser therapy, topical treatments
Medication	Imiquimod, podophyllin, 5-fluorouracil
Prognosis	Variable; risk of recurrence and malignant transformation
Frequency	Rare
Deaths	N/A

Giant condyloma acuminatum, also known as Buschke–Löwenstein tumor, is a rare, slow-growing, locally destructive tumor that occurs in the anogenital region. It is associated with infection by certain types of the human papillomavirus (HPV), particularly types 6 and 11. Unlike typical genital warts, giant condyloma acuminatum can invade deeper tissues and has a higher risk of malignant transformation.

Clinical Presentation

Giant condyloma acuminatum typically presents as a large, cauliflower-like mass in the anogenital region. It can occur in both males and females, often affecting the penis, vulva, perineum, and perianal areas. The lesions are usually exophytic, meaning they grow outward from the surface of the skin. Patients may experience symptoms such as discomfort, pain, and bleeding, especially if the lesion becomes ulcerated or infected. Due to its size and location, the tumor can cause significant psychological distress and social embarrassment.

Pathophysiology

The development of giant condyloma acuminatum is strongly linked to infection with low-risk HPV types, particularly HPV 6 and 11. These viruses cause hyperproliferation of the epithelial cells, leading to the formation of large, wart-like growths. Unlike high-risk HPV types, which are associated with cervical cancer and other malignancies, the low-risk types involved in giant condyloma acuminatum are less likely to cause cancer. However, due to the tumor's potential for local invasion and destruction of surrounding tissues, it is considered a borderline malignancy. There is also a risk of transformation into squamous cell carcinoma, particularly if the lesion is left untreated.

Diagnosis

Diagnosis of giant condyloma acuminatum is primarily clinical, based on the characteristic appearance of the lesion. A biopsy may be performed to confirm the diagnosis and rule out malignant transformation. Histologically, the tumor shows features of acanthosis, papillomatosis, and koilocytic changes, which are indicative of HPV infection.

Treatment

The treatment of giant condyloma acuminatum involves surgical excision of the lesion. Due to the tumor's size and potential for local invasion, complete removal can be challenging. In some cases, additional treatments such as laser therapy, cryotherapy, or topical agents may be used to manage smaller lesions or residual disease. Close follow-up is essential to monitor for recurrence, as the tumor has a high rate of recurrence if not completely excised. In cases where malignant transformation has occurred, more aggressive treatment, including radiation therapy or chemotherapy, may be necessary.

Prognosis

The prognosis for patients with giant condyloma acuminatum depends on the extent of the disease and the success of surgical treatment. Early diagnosis and complete excision of the tumor are associated with a better outcome. However, the risk of recurrence and potential for malignant transformation necessitate long-term follow-up.

See also

• Human papillomavirus
• Genital warts
• Squamous cell carcinoma
• Buschke–Löwenstein tumor